Caroline Litchfield $MRK SEC Form 4 Insider Trading

Caroline Litchfield has filed a total of 2 insider trades in $MRK since 2021. Their most recent trade was a sale of 38,291 shares, made on Feb 14, 2024. Their largest trade was a sale of 38,291 shares, made on Feb 14, 2024. We estimate that they now own shares of $MRK, worth an estimated $7.1 million.

Insider Trading at $MRK

There have been a total of 91 insider trades reported at $MRK since 2021, with 18,241 shares purchased and 5.1 million shares sold. The most active insider traders in $MRK stock have been Kenneth C Frazier, Steven Mizell, and Joseph Romanelli. The most recent trade was a sale of 6,000 shares reported by David Michael Williams (EVP,Chief Info&Digital Officer), made on Feb 13, 2025.

$MRK Executives and Stock Owners with Insider Trades

• Kenneth C Frazier, Executive Chair

• Steven Mizell, EVP, Chief HR Officer

• Joseph Romanelli, President, Human Health Int?l

• Sanat Chattopadhyay, Exe V-P & Pres. MMD

• Richard R. Deluca, EVP&Pres, Merck Animal Heallth

• Jennifer Zachary, EVP, General Counsel

• Johannes Jacobus Oosthuizen, President, U.S. Market

• Robert M Davis, Chairman, CEO & President

• Rita A Karachun, Sr. VP Fince-Global Controller

• Robert M Davis, CEO & President

• Caroline Litchfield, EVP & CFO

• David Michael Williams, EVP,Chief Info&Digital Officer

• Cristal N Downing, Chief Comm. & Public Afrs Ofcr

• Dean Y Li, Executive VP & President, MRL

• Frank Clyburn, EVP & Pres ? Human Health

• Julie L. Gerberding, EVP, Chief Patient Officer

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.